More than three dozen attorneys general are urging the FDA to take “decisive action” against counterfeit obesity drugs.

One participant lost 22% of her weight in nine months — substantially faster than the rate seen with approved GLP-1 drugs ...

Eli Lilly wants to take big swings in Alzheimer's, ALS, chronic pain and other difficult diseases after its success in ...

The warning signs of sleep apnea in obese patients include loud snoring, choking at night, morning headache and mood changes.

Obesity significantly reduced the effectiveness of febuxostat-based urate-lowering therapy among men with gout, a recent ...

Obesity is more than just a diet and exercise issue; it's deeply intertwined with psychological and social factors. Experts ...

Experts reveal how to navigate psychological barriers to achieve healthier eating and exercise habits for weight loss.

Scientists found brainstem neurons that tell mice when to stop eating, offering insights for obesity treatments. Columbia ...

In ongoing trials of Eli Lilly’s (LLY) next-generation obesity drug, several trial participants are losing too much weight, STAT’s Elaine Chen ...

Next-generation obesity drugs will work differently from Ozempic and Wegovy — aiming to deliver greater weight loss with ...

Higher BMI in early adulthood and midlife is linked to better memory performance, particularly in men and Black Americans, ...

For obese workers, even the prevalence rates for multiple sclerosis and lupus are higher. For workers at big U.S. employers, ...